Vancouver, British Columbia – TheNewswire – October 16, 2020 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) has responded through their joint venture Plasm Pharmaceutical (“Plasm”) to Health Canada’s Information Request Notice (“IRN”). The questions as posed by Health Canada are considered a formality as Plasm Pharmaceutical, continues to prepare for aContinue reading “Naturally Splendid Responds to Health Canada’s Information Request Notice”
Tag Archives: investing in Natually Splendid Enterprises
Naturally Splendid Closes Private Placement, Secures Laboratory Facility
— Naturally Splendid Enterprises Ltd. (“Naturally Splendid”) (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) is pleased to announce that it has closed its non-brokered private placement financing for a total of 15,887,503 units (the “Units”) at $0.06 per Unit, for total gross proceeds of $1,053,250 (the “Offering”). Due to oversubscribed demand, the private placement financing was increased from 14,166,667 Units to 17,554,167.Continue reading “Naturally Splendid Closes Private Placement, Secures Laboratory Facility”
Naturally Splendid Passes Facility Audit for Annual SQF Certification
— Naturally Splendid Enterprises Ltd. (“Naturally Splendid”) (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) is pleased to announce the Company’s wholly owned division, Prosnack Natural Foods (“Prosnack”) has passed it’s annual audit of its Safe Quality Food certified food manufacturing facility. The Safe Quality Food (SQF) Program is a rigorous food safety and quality program that is known by retailers, brand owners, andContinue reading “Naturally Splendid Passes Facility Audit for Annual SQF Certification”
Health Canada Requests Clinical Trial Protocol Details
– June 30, 2020 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid”) (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) is pleased to provide the following update in regards to the Clinical Trial Application (CTA) to Health Canada submitted May 17, 2020 as a treatment for Covid-19 with the target drug, Cavaltinib(TM). The Company continues to navigate the fast track CTA process withContinue reading “Health Canada Requests Clinical Trial Protocol Details”
Naturally Splendid Launches Ambassador Program featuring Professional Sports Personalities
— Naturally Splendid Enterprises Ltd. (“Naturally Splendid”) (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) is pleased to provide the following update. Naturally Splendid has executed a Memorandum of Understanding with Atlas 365 Inc. for the purpose of establishing an on-line Ambassador Program to market various Naturally Splendid product lines to further enhance the recently announced expanded e-commerce strategy. The first line toContinue reading “Naturally Splendid Launches Ambassador Program featuring Professional Sports Personalities”
Naturally Splendid Signs Sales Distribution Agreement with Ecotrend Ecologics
Vancouver, British Columbia – TheNewswire – May 6, 2020 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) announces the Company has signed a Sales Distribution Agreement with Vancouver based Ecotrend Ecologics (“Ecotrend”), to market certain Company Brands across Canada. The first product that Ecotrend will market and distribute for Naturally Splendid, is theContinue reading “Naturally Splendid Signs Sales Distribution Agreement with Ecotrend Ecologics”
